Literature DB >> 28551337

Margin Analysis: Malignant Salivary Gland Neoplasms of the Head and Neck.

Robert A Ord1, Naseem Ghazali2.   

Abstract

There are no established protocols for the optimum surgical margin required for salivary gland malignancies. Factors including histologic diagnosis and TNM stage have been shown to be important in prognosis and survival outcome and mandate special consideration of margin size. Salivary cancers are treated differently at different anatomic sites, and different histologic types show a propensity for major or minor glands. Low-grade malignancies are treated with soft tissue margins of 1 cm or less. The facial nerve is preserved unless infiltrated and encased. Adenoid cystic carcinoma and carcinoma ex pleomorphic adenoma require more complex planning to obtain negative margins. Crown
Copyright © 2017. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Malignancy; Salivary gland; Surgical margins

Mesh:

Year:  2017        PMID: 28551337     DOI: 10.1016/j.coms.2017.03.008

Source DB:  PubMed          Journal:  Oral Maxillofac Surg Clin North Am        ISSN: 1042-3699            Impact factor:   2.802


  3 in total

Review 1.  [Surgery for parotid gland cancer-controversial and proven aspects].

Authors:  Konstantinos Mantsopoulos; Heinrich Iro
Journal:  HNO       Date:  2022-05-17       Impact factor: 1.284

2.  Inhibition of DEC2 is necessary for exiting cell dormancy in salivary adenoid cystic carcinoma.

Authors:  Xiao Yang; Jia-Shun Wu; Mao Li; Wei-Long Zhang; Xiao-Lei Gao; Hao-Fan Wang; Xiang-Hua Yu; Xin Pang; Mei Zhang; Xin-Hua Liang; Ya-Ling Tang
Journal:  J Exp Clin Cancer Res       Date:  2021-05-14

3.  CXCR5 induces perineural invasion of salivary adenoid cystic carcinoma by inhibiting microRNA-187.

Authors:  Mei Zhang; Jia-Shun Wu; Hong-Chun Xian; Bing-Jun Chen; Hao-Fan Wang; Xiang-Hua Yu; Xin Pang; Li Dai; Jian Jiang; Xin-Hua Liang; Ya-Ling Tang
Journal:  Aging (Albany NY)       Date:  2021-06-10       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.